Samuel Candler Dobbs Professor of Chemistry
Emory University
Dr. Liotta has been involved in the development of several anti-retroviral drugs that are currently in use around the world. Most recently, Dr. Liotta was instrumental in the development of the AIDS drug Emtriva®. In this interview, Dr. Liotta discusses his current work in the development of anti-cancer drugs and cancer chemoprevention.
Interview Questions
About Dr. Liotta
(Time:
)
Why did you choose to work on drug development as a career?
(Time:
38sec
)
What guides your approach to drug discovery?
(Time:
26sec
)
What do you look for when identifying cancer drug candidates?
(Time:
2min
32sec
)
How do you use computers in the design of cancer drugs?
(Time:
40sec
)
How do computers model the biology behind human disease?
(Time:
39sec
)
What is the process by which you identify possible cancer drugs?
(Time:
2min
41sec
)
How does your approach to drug discovery differ from past efforts?
(Time:
1min
37sec
)
Is it possible to develop agents that work to prevent cancer development?
(Time:
1min
18sec
)
What is sphingosine and what does it do in cells?
(Time:
1min
20sec
)
Can sphingolipids be chemopreventive agents?
(Time:
19sec
)
Can drugs be synthesized for individual patients?
(Time:
1min
9sec
)
What is metastasis and why does it cause complications?
(Time:
31sec
)
What are some concerns that motivate developing safer drugs?
(Time:
54sec
)
Top